Natera, Inc. (NTRA)
NASDAQ • Healthcare
Last close at October 2, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Natera, Inc. currently loses $9.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 32 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Natera beat consensus on both revenue and EPS in preliminary second fiscal quarter of 2026 results reported Aug. 6, as revenue rose about 38% to roughly $752.8 million and outpaced the $661.2 million estimate by about 14%, while EPS came in at -$0.47 versus the -$0.49 consensus, a beat of about 5%. Growth was led by the United States, the largest contributor at about $685.6 million, up 39%, while insurance carriers brought in roughly $658.1 million, also up 39%, and laboratory partners added about $28.8 million, up 38%; gross margin held at 64.5% even as operating margin was -10.1% on operating income of negative about $75.8 million. Net income improved 34% to a loss of about $67.0 million from $100.9 million a year earlier, EPS was up 37% from -$0.74, and operating cash flow was about $40.2 million.
About Natera, Inc.
Natera, Inc. (NASDAQ: NTRA) develops genetic testing and molecular monitoring products for healthcare, operating in diagnostics and research, with $2.3 billion in revenue in FY2025. Its menu spans reproductive health, oncology, and transplant testing, pairing laboratory-developed assays with direct sales and partner distribution on a global basis.
Today's Snapshot
NTRA closed slightly higher at 410.35, in line with a flat sector. The day ended with NTRA within 4% of its 52-week high of 427.47.
Trading Volume
Above 10d avg 1.8M
1.8M
vs S&P 500 Today
Moderate Underperformance
-0.32%
Updated: October 2, 2026 at 20:20 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$264.81 - $399.64Buy
- RSI (14)78.15Sell
- Stochastic %K (14, 3, 3)82.67Sell
- MACD Level (12, 26)25.25Buy
Peers & Related Assets
Get premium market insights delivered directly to your inbox.